about
negative regulation of fibroblast proliferationnegative regulation of smooth muscle cell proliferationnegative regulation of osteoblast proliferationnegative regulation of neural precursor cell proliferationnegative regulation of epithelial cell proliferationnegative regulation of cardiac muscle cell proliferationnegative regulation of cell proliferation involved in heart morphogenesisnegative regulation of chorionic trophoblast cell proliferationnegative regulation of glial cell proliferationnegative regulation of mesenchymal cell proliferationnegative regulation of cell proliferation involved in contact inhibitionnegative regulation of myoblast proliferationnegative regulation of fat cell proliferationnegative regulation of chondrocyte proliferationnegative regulation of leukocyte proliferationnegative regulation of stem cell proliferationnegative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferationnegative regulation of cell proliferation involved in kidney developmentnegative regulation of trophectodermal cell proliferationnegative regulation of cell proliferation involved in compound eye morphogenesisnegative regulation of mammary stem cell proliferationnegative regulation of hemocyte proliferationnegative regulation of synoviocyte proliferationnegative regulation of skeletal muscle cell proliferationnegative regulation of cell proliferation in bone marrownegative regulation of hair follicle cell proliferationnegative regulation of sebum secreting cell proliferationnegative regulation of germ cell proliferationnegative regulation of growth plate cartilage chondrocyte proliferation
P279
CD9 moleculePeroxisome proliferator activated receptor gammaCytochrome P450 family 27 subfamily B member 1Zinc finger and BTB domain containing 1624-dehydrocholesterol reductaseCytochrome P450, family 27, subfamily b, polypeptide 1FukutinTransformation related protein 53B cell leukemia/lymphoma 2Insulin-like growth factor 1Interleukin 10Interleukin 6Forkhead box P3Amyloid beta (A4) precursor proteinTransformation related protein 73Androgen receptorInterleukin 1 alphaInterleukin 1 alphaPhosphatase and tensin homologLeukemia inhibitory factorHeme oxygenase 1Harvey rat sarcoma virus oncogeneGLI-Kruppel family member GLI3Adenosine A1 receptorNeurofibromin 2Interferon regulatory factor 6Neurotrophic tyrosine kinase, receptor, type 1Cyclin-dependent kinase inhibitor 1A (P21)Catenin (cadherin associated protein), beta 1Bone morphogenetic protein 7Bone morphogenetic protein 2Bone morphogenetic protein 4V-raf-leukemia viral oncogene 1Bone morphogenetic protein 5SMAD family member 1SMAD family member 2SMAD family member 3SMAD family member 4SMAD family member 6SMAD family member 6
P682
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancerIn vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cellsC-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrestSignalling through CD30 protects against autoimmune diabetes mediated by CD8 T cellsMETH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activityCharacterization of zinc-alpha(2)-glycoprotein as a cell adhesion molecule that inhibits the proliferation of an oral tumor cell lineThe tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal regionHuman 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activityChanges in levels of normal ML-1 gene transcripts associated with the conversion of human nontumorigenic to tumorigenic phenotypesEpstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32Cloning of human Ca2+ homoeostasis endoplasmic reticulum protein (CHERP): regulated expression of antisense cDNA depletes CHERP, inhibits intracellular Ca2+ mobilization and decreases cell proliferationTwo RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor propertiesLHRH might act as a negative autocrine regulator of proliferation of human ovarian cancerRelationship between contact inhibition and intranuclear S100C of normal human fibroblastsalpha(1)-adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cellsCD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptorThe TSC1 gene product, hamartin, negatively regulates cell proliferationGros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecanIdentification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinomap56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transductionThe TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain proteinHuman T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasisAssociation of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27(Kip1) inductionInduction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicityCOP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phasePurification, localization, and expression of human intestinal alkaline sphingomyelinaseLoss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumourscDNA cloning of IL-1 alpha and IL-1 beta from mRNA of U937 cell lineING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cellsKnocking down Wnt9a mRNA levels increases cellular proliferationSubcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variantsPhysical and functional interaction between HCV core protein and the different p73 isoformsThe CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrestBiological activity of interleukins-28 and -29: comparison with type I interferonsOpioid and nicotine receptors affect growth regulation of human lung cancer cell linesLyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitorsRelease of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
P921
Q14818071-1ABECA25-D13F-4245-A9A9-01006CAE33DEQ14818124-61492544-794D-46B3-B89A-81A9EB542C29Q14863407-63D71731-0108-4280-B5C6-95B2C3272152Q14865186-7EBD37E7-682E-4566-8FD4-05EBD1883693Q14873008-8FA77BEA-5310-41B9-9BB8-BB3C83D92BDBQ14903032-1ADB7719-4C73-4A8B-AF8F-7EA5D5DFFC27Q14903396-FC6FBA9E-BAB6-4008-AC00-5A6FB1C369C8Q14905094-C9C1D809-6496-4C94-B883-0C98427352B4Q14907476-A6289F88-B4C1-4357-8E68-53DD54972FFDQ15314782-8B980EC6-FA62-4EE3-B911-86C9051F573EQ15334977-715902E1-F13D-4DEF-B7AC-0F128C81C8F0Q21095616-4EF897F0-5E6F-42EA-90C0-E4C3786C3296Q21105815-CF6E1EC1-7FF0-46C9-B571-BB6A76A0E7F0Q21106676-48592546-208C-4E6F-A85A-CB3E22AC4E72Q21111905-0BD62B2B-3743-4E46-82A7-08EA0AB99BE7Q21118135-09170599-CC53-47E5-A049-8B29B60D3A9DQ21157476-E2476E3F-41E6-4B3E-9C19-0919229ADE9AQ21495725-342930EF-09CC-445E-8B5D-0B6F780D088DQ22284639-4B63C60A-5672-4D17-97E8-C6DE5CF3BA20Q22302489-175201D1-BC3E-4D2F-8BB9-CC396BC966C8Q22302512-CBBDB127-F021-4DEA-9863-ADBDA04E6A29Q22302625-FCEC855B-07AC-4F0E-ACAD-B64FF0E55DCFQ22304639-BCC78EBD-CB0B-471F-848F-FB23ADA5DC0CQ22304646-309EA2BB-356F-41C9-BDF5-C1A8EB2252E5Q22304649-140B5480-784E-44C3-803C-3767DC157811Q22304652-886B67C6-AF37-4A29-8D31-C12FDD9EB081Q22304655-885038FE-1CA7-4908-BDA0-E1AE388FC203Q29572957-CD509776-54B5-4FDC-B79E-B3D83A433D3DQ34311990-C8E61644-B3D5-4C86-B5EE-0BFB6ACA099D
P279
Q1058190-2C0FA969-C0A0-479F-AF30-CA72355DE8BFQ1084878-9EDAFAC7-66FB-444E-8A53-D673BE8ADF6DQ1149122-9CC554EA-EC20-42E7-A425-0C109C29E581Q11705457-767D6111-4F25-4B92-AC95-155798EB9A85Q14599665-E827BD51-358C-41D9-B8CB-E448F44C595DQ14599791-2E13E839-E8D4-42C1-B8FC-6E2524176E65Q1473399-88174017-6483-486D-B95D-6213AFFEB16CQ14818136-01E27362-A8FB-440B-9A15-71EC03E0F041Q14818136-6CC649C1-6E51-495A-9FB2-A1B1F4FE6B36Q14863583-EDB9C173-988E-4AA4-A9E2-FC5CFC88F622Q14863723-2F60159D-96F6-4DEE-9734-F6ECCC6AE9E6Q14864467-18836A33-BD45-40E7-9463-53D285E81E9BQ14865240-6B0ED37A-5B83-4E7A-A48E-0B209B565E25Q14865673-C4179713-A826-4622-AF43-55578768586AQ14865884-4C0E8F72-660D-4B4B-AF63-87A22B8A439CQ14872987-92B1DCA2-AA6E-4517-9AE9-9DD407344AEBQ14873035-0E1BC7F4-F36F-49EC-AFA9-35D5BC8DE9D6Q14878193-1AC2785B-60F5-4D40-A28A-1BB37A8FB40AQ14878201-A323C17A-BAB2-4A11-8E5E-B7BA84B1D23CQ14878408-D616EC84-4266-4D4D-8204-1C342FF94C81Q14878799-20BE5B32-934B-47DE-B889-0E377A6B1550Q14882925-D50F98C6-9ECF-4E64-9B66-A3FAA0CE3B3BQ14884142-E192977D-2316-4F68-BA5B-BB608376ADDBQ14886933-BC8E325C-3BC1-4683-BD39-54B55D5528BFQ14888630-060506A2-C950-4DE1-A4AB-F5BFDC46D99DQ14889820-80B1E8C5-F094-4669-AE0E-700ADBB93C91Q14890131-E73DAB3B-FDF6-44E5-ADC5-188E177AAC35Q14901156-97BBA03A-9C27-4BB5-B12B-012D38DE871AQ14902457-E0A21683-42F4-4106-A5D9-4B8BD0D90ACBQ14902827-22C2EAA2-CAD9-4190-818B-A3F17A209A14Q14902827-8D6ACE8C-5E5E-4827-AD13-5A878F681575Q14903113-1CBFDA01-9CE8-4C0D-A1C6-8C7FA120A1A9Q14903156-E72EFF82-62E6-4508-A32F-70BC8B0E2FD1Q14903410-5EE5A6C8-FCF1-4381-9B17-5AB3B9B041CDQ14903577-DB5962E4-306E-4474-B712-C6B0845CF368Q14903761-7895CB87-C18E-4F40-B006-9BCF80F7D493Q14903821-AB714F23-183E-49C7-8E5C-11370D162E2EQ14903951-A887FFDE-BB39-4866-9EDC-8B2A7DCAB992Q14903978-25A52D6D-5C96-46E2-BDBD-7BBD51EE9EB2Q14904159-64C4BC60-1CA2-4CEE-B06E-9BECBD3E04B7
P682
Q22004026-3381071F-8825-4CD0-A48E-A90C4EA83330Q22008658-7B92AEB0-8052-4151-A662-CC78A45ADD7BQ22008681-F6A0C4C2-FCA0-41A3-825B-86B3606E6A21Q22009150-36CCE238-8395-442A-8446-8E7A4A822FD7Q22010478-BD22DF58-E184-4F7D-A4C0-2D5BA2FC3748Q22010482-7E7EF5A1-6082-4F3A-99D6-C63B0385AE62Q22010498-F5A43472-2E48-43C7-A861-B04E7A2E37F1Q22010565-611064F2-BA04-47E8-8DD4-082C1D2DAB47Q22010754-56E933F1-EEE5-44A0-B002-87C86E17F99DQ22010776-37008B62-DC72-41BD-A8CF-7B3EE90FBEEBQ22010989-584A2EA3-6FDF-4037-A64D-91C54090C6CDQ22254024-EAD7CE01-4EE9-4829-B570-4336FA8CC0E5Q22254194-DB0AFE9C-8598-4E9D-A896-A460F4A738DFQ22254198-58CB302F-C3C3-4A3C-83B6-C51034527139Q22254241-AB7D05FD-AE76-44A5-8CF4-290C5B28EEAFQ22254284-84C233D5-5DE8-425E-87E5-B5BA72C8B5A5Q22254444-2F444EDD-87E8-4A0E-B763-9DD0DB873E91Q22254689-36B69FF5-0F37-457D-99EE-AFF647B9D58DQ24290125-4371362F-AF63-47CE-976F-16BABF00F064Q24290300-04905951-5E81-44DA-B993-BD67CE9EC612Q24290345-88A8445D-6FD5-4FF4-9FFC-A7392835B30CQ24291361-87C56610-21E8-41A6-8E2D-FFD1143E55DBQ24291927-055C5BF4-A999-4DBB-AEC6-B53E3B8240B5Q24292757-87F05A49-BACD-4695-8781-AC165A8BF3BEQ24292853-DDD4D8DF-BB28-4345-8DA2-270073287306Q24293008-431B094B-1D3C-4818-86C9-DFFDC9EB08F3Q24293186-73BFE4E5-181D-46B4-9270-A8A3341B09D6Q24293399-6049F7F5-4A84-4F7C-94C8-2126E0D22C55Q24299084-47B2E562-FE34-4801-ABE4-AAC2EAE0DDDBQ24299088-E6E5A855-C776-44B3-951F-087064072F41Q24299138-E2076765-697F-4335-AF0A-8302A20861D9Q24299273-4A58295B-A8F2-4421-8C4E-7C3DECDE7E52Q24299779-BE909154-7A33-478B-94D8-68CE5F543B65Q24300188-CB3FB672-5D15-470D-ACA1-7C9736530C6CQ24301094-DA5104A7-52F2-44DD-809B-F15A232D3F23Q24301285-E29CED95-4669-4043-BF60-8EF40E9BE902Q24302340-C309EFDD-DE57-4062-A7F1-3B641E74EE70Q24303652-AA860820-DF1D-4BFD-A19C-97568C13882CQ24305025-6D425638-08B4-406D-BDE0-567D54559DB9Q24306649-59551F6D-FD6A-4EF3-812D-68BC92838A9D
P921
description
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
@en
biologisch proces
@nl
name
negatieve regulatie van celproliferatie
@nl
negativ regulering av celleproliferasjon
@nn
negative regulation of cell proliferation
@en
негативная регуляция пролиферации клеток
@ru
type
label
negatieve regulatie van celproliferatie
@nl
negativ regulering av celleproliferasjon
@nn
negative regulation of cell proliferation
@en
негативная регуляция пролиферации клеток
@ru
altLabel
GO:0008285
@en
GO:0008285
@nn
down regulation of cell proliferation
@en
down-regulation of cell proliferation
@en
downregulation of cell proliferation
@en
nedregulering av celleproliferasjon
@nn
prefLabel
negatieve regulatie van celproliferatie
@nl
negativ regulering av celleproliferasjon
@nn
negative regulation of cell proliferation
@en
негативная регуляция пролиферации клеток
@ru
P2888
P686
GO:0008285